Oncogenic microRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum - Wikidata - awgldk - TriplyDB

Oncogenic microRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum

Oncogenic microRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum

http://www.wikidata.org/entity/Q33824699

about

The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies Appraising MicroRNA-155 as a Noninvasive Diagnostic Biomarker for Cancer Detection: A Meta-Analysis miRNAs as potential biomarkers in early breast cancer detection following mammography MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA ING5 suppresses breast cancer progression and is regulated by miR-24 Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal A subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel.Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases Critical analysis of the potential for microRNA biomarkers in breast cancer management.Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker The Roles of MicroRNAs in Breast Cancer Association of Pre-miR-146a rs2910164 Polymorphism with Papillary Thyroid Cancer Up-regulated miR-155-5p promotes cell proliferation, invasion and metastasis in colorectal carcinoma A systematic investigation based on microRNA-mediated gene regulatory network reveals that dysregulation of microRNA-19a/Cyclin D1 axis confers an oncogenic potential and a worse prognosis in human hepatocellular carcinoma.Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC.The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma.Novel combination of serum microRNA for detecting breast cancer in the early stage.Overexpression of microRNA-24 increases the sensitivity to paclitaxel in drug-resistant breast carcinoma cell lines via targeting ABCB9.Upregulation of microRNA-181b inhibits CCL18-induced breast cancer cell metastasis and invasion via the NF-κB signaling pathway.A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer.Role of miR-155 in drug resistance of breast cancer.Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.miR-98-5p Acts as a Target for Alzheimer's Disease by Regulating Aβ Production Through Modulating SNX6 Expression.Breast cancer stem cells programs: enter the (non)-code.miR clusters target cellular functional complexes by defining their degree of regulatory freedom.Effect of miR-155 knockdown on the reversal of doxorubicin resistance in human lung cancer A549/dox cells.miR-24 regulates CDKN1B/p27 expression in prostate cancer.Diagnostic significance of circulating multiple miRNAs in breast cancer: a systematic review and meta-analysis.Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.The miR-17-92 cluster as a potential biomarker for the early diagnosis of gastric cancer: evidence and literature review.A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer.MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers.Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth.Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas.

P2860

Q26744831-B4555576-FF37-49FE-B295-93A433D013DF Q26748881-CDB33930-F422-41D4-8B6D-7686FF96501C Q26772056-5BD670FC-D4CC-4B8B-B69E-4474A5BF73A5 Q26773094-88F9EE52-49CD-47BD-A793-C9E71B5A58F0 Q26775086-27C5DB25-D55D-41F1-858C-6CB161ED33AA Q26801108-0272025A-FE9E-4540-BB5F-6CDB5839CCD5 Q27011221-6166C5FB-3510-4401-AEB8-EFFAC3A4E097 Q33654764-DE62EFE7-DA1F-4F98-A93E-0B18D238C3D3 Q34066078-90E0FEF4-948C-4F20-97A2-6A13E56458E9 Q34391443-0F37C659-8032-4AB3-B1CF-BCF114507221 Q35137273-165B8B1E-644F-41B8-B7DE-5150E355DB08 Q35247522-0813B739-B5B3-4736-B7B4-4DD5B3ADDF6F Q35818407-1E289DE2-57C3-4258-A22E-0EA2B2D86D26 Q35868081-0D07E5E1-32DE-4232-B10C-1489A1F1C70F Q35919236-C942A83E-C0FC-4828-A0F8-E297867C863C Q36191096-9E16580B-F0B4-4F45-AE93-39394B864E5B Q36214432-34BA8FFA-054B-4021-ACE1-1945BB826CEE Q36333514-90DCC86E-8F12-4A42-B7B5-267AE8FC5F44 Q36541517-27D5BC0F-5C56-4AFC-B918-D970CCC7319B Q36746303-D5389C55-7F1C-494D-9E38-5D05D8C03105 Q37407242-614C101B-B03C-4E2E-9687-9E372AD0C335 Q37582426-7898B412-B52B-44D5-99CF-D87C9BC00D7B Q37641977-BD5F1054-D43C-4A73-9976-CF4E923094D7 Q38368383-44D619C0-D3AD-4CF5-B480-602C4F8A157F Q38573871-C243C019-633F-46A1-98B4-D9BD934F458C Q38751069-C3CD00FE-C012-48AC-8052-9948841E42FA Q38765793-C96FE16E-D6F6-462E-97B8-ECE546F7AE12 Q38771877-05C5EBBD-37FC-4012-A566-4743A4AF7DC6 Q38792745-031AB3BB-FA51-4863-A918-88AD3D68AD38 Q38796425-CB0B1D31-3E16-4388-B564-96F6DE3064A2 Q38845874-6A42D663-3D49-4CD3-9042-BCEA11C88C94 Q38855547-804C0082-B4C8-46A0-9153-976F185DE087 Q38902431-3F8E5A2A-060B-4355-92F8-B9B2F1616DD3 Q39126705-2A395A71-A5AB-4691-8611-934936A244E7 Q40420399-7852B277-5EB2-4AE8-8D4C-FF46C9DCDCC6 Q40579865-F9FF6FE0-86B6-4EF7-AFC1-5EA456518FAD Q41093491-FECEA17B-4809-4CFF-8EF4-3D91B896B039 Q42122645-50CF0284-EB8C-4DB8-80FD-0DE13503C77E Q46366691-0000FD88-0246-4CC4-991F-B9513C159D56 Q47122404-6251AFDD-5F87-4515-9677-C9F8EBA8FB5E

P2860

Oncogenic microRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum

http://www.wikidata.org/entity/Q33824699

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Oncogenic microRNAs: miR-155, ...... f early breast cancer in serum

@ast

Oncogenic microRNAs: miR-155, ...... f early breast cancer in serum

@en

type

label

Oncogenic microRNAs: miR-155, ...... f early breast cancer in serum

@ast

Oncogenic microRNAs: miR-155, ...... f early breast cancer in serum

@en

prefLabel

Oncogenic microRNAs: miR-155, ...... f early breast cancer in serum

@ast

Oncogenic microRNAs: miR-155, ...... f early breast cancer in serum

@en

P1433

Q33824699-83136932-E41B-4EE1-B54C-5FAD76FF12D6

P1476

Q33824699-015E752D-A979-4528-8996-ABAFC1654CF2

P2093

Q33824699-32D2491C-B00A-4DC5-9D4E-8A47F9BCAB1D

Q33824699-441466E3-605C-402A-A27D-C75F3DF6683A

Q33824699-5046866F-A1AB-4220-B0ED-46963407BFB7

Q33824699-60F04AFF-F93E-4059-A623-B6D5AB115C4E

Q33824699-B44BEB18-2A87-48D3-ADF9-87FCBCF3EEC6

P2860

Q33824699-1148CF28-ED72-4C38-8323-2758759F0F9B

Q33824699-125BDDB2-AFBA-4FDE-AE51-82EB0C63B9EF

Q33824699-17BFAAF1-68D2-4BA0-B9E7-07805328D9DF

Q33824699-2D7139E4-683A-4A1D-9BD5-B168D1362988

Q33824699-2E2BF9C0-42CC-4181-A724-4B7A6C810E95

Q33824699-43C93D4B-6903-4CF0-881A-340880BA9013

Q33824699-454DB011-1234-4B34-B6A1-D7C93663D347

Q33824699-519488CD-EBED-4A6D-BCB4-F88994DBF285

Q33824699-5AE85772-A003-411D-BC0D-B60C2726752E

Q33824699-5BFAEC4F-4B0A-489B-868F-29E2C5ABBA96

P2888

Q33824699-EB97C140-7BE1-403B-B1E8-19D605DB42D7

P304

Q33824699-EAA24D26-8AAC-4E20-90FB-B6A5FA5D1611

P31

Q33824699-DAF419F3-6145-44AB-A26A-C327DA0B4F84

P356

Q33824699-56829A7A-FBFB-4797-AC1C-7369027F2366

P407

Q33824699-38C91C36-071C-4721-A23D-BEF2E9F9720B

P478

Q33824699-BD058D4F-FF5B-43ED-B180-1B4302C745FE

P50

Q33824699-280DF896-2169-4AD4-80FF-7819B7B5A139

Q33824699-69266D37-4247-4E83-AC1B-73EF12446D2E

Q33824699-A32454B8-164B-4EC1-B7D4-EC163A0EC393

P577

Q33824699-B0C635FE-C294-475B-98D8-29B3C090BB59

P5875

Q33824699-B17CBECC-BFFB-433E-AC8C-B759DA8A7A2D

P6179

Q33824699-CB3B5959-46AD-4A6F-B45A-960A38266568

P698

Q33824699-25C49EA2-4507-4A5B-A943-DDED29DDFE0D

P921

Q33824699-F1D2122F-6DBD-49DD-BBED-46B4126C05C2

P932

Q33824699-332531F0-7A52-4071-9075-A2399E3733D1

P356

1471-2407-14-448

P1433

P1476

Oncogenic microRNAs: miR-155, ...... f early breast cancer in serum

@en

P2093

Jiri Bartos

http://www.w3.org/2001/XMLSchema#string

Marek Sochor

http://www.w3.org/2001/XMLSchema#string

Pavel Burda

http://www.w3.org/2001/XMLSchema#string

Tomas Stopka

http://www.w3.org/2001/XMLSchema#string

Vit Pospisil

http://www.w3.org/2001/XMLSchema#string

P2860

Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing

MicroRNA gene expression deregulation in human breast cancer

MicroRNA signatures in human cancers

A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer.

STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer.

MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene.

MicroRNA sequence and expression analysis in breast tumors by deep sequencing.

Analysis of serum genome-wide microRNAs for breast cancer detection.

Novel direct targets of miR-19a identified in breast cancer cells by a quantitative proteomic approach.

Serum microRNA-155 as a potential biomarker to track disease in breast cancer

P2888

1471-2407-14-448

P304

448

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-14-448

http://www.w3.org/2001/XMLSchema#string

P407

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263294347

http://www.w3.org/2001/XMLSchema#string

P6179

1048760144

http://www.w3.org/2001/XMLSchema#string

P698

24938880

http://www.w3.org/2001/XMLSchema#string

P921

P932

4075993

http://www.w3.org/2001/XMLSchema#string